Follow the JW홀딩스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, JW홀딩스 has published 49 public disclosures. Market capitalisation: €257.7bn. The latest transaction was reported on 3 July 2026 (Purchase). Among the most active insiders: 이경하. Every trade is openly available.
49
Insider Decl.
n/a
Thresholds
n/a
43 ops.
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 821 of 28,932 companies
82.3
score / 100
Value
97
Quality
68
FCF yld39%
Earn yld21%
EV/EBITDA3.1x
ROE27%
Gross mgn51%
Net mgn6.0%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
JW홀딩스 is a company in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and commercialization of pharmaceutical products.